Emily Sims

445 total citations
18 papers, 361 citations indexed

About

Emily Sims is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Emily Sims has authored 18 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Emily Sims's work include Mast cells and histamine (13 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Click Chemistry and Applications (3 papers). Emily Sims is often cited by papers focused on Mast cells and histamine (13 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Click Chemistry and Applications (3 papers). Emily Sims collaborates with scholars based in United States, Canada and Poland. Emily Sims's co-authors include Veerendra Munugalavadla, Reuben Kapur, Peilin Ma, Raghuveer Singh Mali, Rebecca J. Chan, Baskar Ramdas, Jovencio Borneo, Holly Martin, Joydeep Ghosh and Sasidhar Vemula and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Molecular and Cellular Biology.

In The Last Decade

Emily Sims

17 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Sims United States 11 210 131 97 69 56 18 361
V Barbetti Italy 11 187 0.9× 90 0.7× 111 1.1× 85 1.2× 24 0.4× 15 381
Stephen J. Loughran Australia 10 315 1.5× 95 0.7× 268 2.8× 53 0.8× 61 1.1× 14 536
Shin’ya Ohmori Japan 14 358 1.7× 132 1.0× 53 0.5× 30 0.4× 54 1.0× 22 511
Delia C. Tang United States 11 212 1.0× 74 0.6× 162 1.7× 64 0.9× 21 0.4× 17 478
Ariel Forrai Australia 8 390 1.9× 65 0.5× 230 2.4× 71 1.0× 66 1.2× 8 617
Fumie Yamamura Japan 5 201 1.0× 269 2.1× 85 0.9× 62 0.9× 115 2.1× 7 510
Nathalie Nadal France 12 179 0.9× 49 0.4× 135 1.4× 84 1.2× 48 0.9× 23 414
Bon-Hun Koo South Korea 9 167 0.8× 66 0.5× 109 1.1× 70 1.0× 62 1.1× 9 399
Samuel J. Taylor United States 10 146 0.7× 73 0.6× 123 1.3× 67 1.0× 15 0.3× 21 333

Countries citing papers authored by Emily Sims

Since Specialization
Citations

This map shows the geographic impact of Emily Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Sims more than expected).

Fields of papers citing papers by Emily Sims

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Sims. The network helps show where Emily Sims may publish in the future.

Co-authorship network of co-authors of Emily Sims

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Sims. A scholar is included among the top collaborators of Emily Sims based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Sims. Emily Sims is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shao, Lijian, Katherine E. Zink, Laura M. Sanchez, et al.. (2020). The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells. Blood. 137(6). 775–787. 36 indexed citations
2.
Gupta, Samir K., et al.. (2018). Endothelial Colony-Forming Cell Function Is Reduced During HIV Infection. The Journal of Infectious Diseases. 219(7). 1076–1083. 7 indexed citations
3.
Kapur, Reuben, Jianjian Shi, Joydeep Ghosh, et al.. (2016). ROCK1 via LIM kinase regulates growth, maturation and actin based functions in mast cells. Oncotarget. 7(13). 16936–16947. 15 indexed citations
4.
Martin, Holly, Raghuveer Singh Mali, Peilin Ma, et al.. (2013). Pak and Rac GTPases promote oncogenic KIT–induced neoplasms. Journal of Clinical Investigation. 123(10). 4449–4463. 37 indexed citations
5.
Mali, Raghuveer Singh, Peilin Ma, Li‐Fan Zeng, et al.. (2012). Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. Blood. 120(13). 2669–2678. 44 indexed citations
6.
Mali, Raghuveer Singh, Baskar Ramdas, Emily Sims, et al.. (2012). p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis. Blood. 119(17). 3951–3961. 9 indexed citations
7.
Mali, Raghuveer Singh, Baskar Ramdas, Peilin Ma, et al.. (2011). Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL. Cancer Cell. 20(3). 357–369. 79 indexed citations
8.
Ma, Peilin, Sasidhar Vemula, Veerendra Munugalavadla, et al.. (2011). Balanced Interactions between Lyn, the p85α Regulatory Subunit of Class IA Phosphatidylinositol-3-Kinase, and SHIP Are Essential for Mast Cell Growth and Maturation. Molecular and Cellular Biology. 31(19). 4052–4062. 17 indexed citations
9.
Ma, Peilin, Raghuveer Singh Mali, Veerendra Munugalavadla, et al.. (2011). The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood. 118(13). 3459–3469. 24 indexed citations
10.
Ma, Peilin, Holly Martin, Emily Sims, et al.. (2009). Role of Intracellular Tyrosine Residues in Oncogenic KIT- Induced Transformamtion.. Blood. 114(22). 1435–1435. 1 indexed citations
11.
Mali, Raghuveer Singh, et al.. (2009). Differential Role of Class 1A PI 3-Kinase Regulatory Subunits in Mast Cell Growth, Maturation and Survival.. Blood. 114(22). 77–77. 1 indexed citations
12.
Mali, Raghuveer Singh, Baskar Ramdas, Veerendra Munugalavadla, Emily Sims, & Reuben Kapur. (2009). Rho Kinase Inhibitors as Potential Therapeutic Agents for Oncogenic KIT, FLT3, and BCR-ABL Induced Leukemogenesis.. Blood. 114(22). 3909–3909. 2 indexed citations
13.
Orschell, Christie M., Jovencio Borneo, Veerendra Munugalavadla, et al.. (2008). Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells. Experimental Hematology. 36(5). 655–666. 13 indexed citations
14.
Munugalavadla, Veerendra, Sasidhar Vemula, Emily Sims, et al.. (2008). The p85α Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration. Molecular and Cellular Biology. 28(23). 7182–7198. 28 indexed citations
15.
Munugalavadla, Veerendra, Emily Sims, Rebecca J. Chan, Stephen D. Lenz, & Reuben Kapur. (2008). Requirement for p85α regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT. Experimental Hematology. 36(3). 301–308. 11 indexed citations
16.
Borneo, Jovencio, Veerendra Munugalavadla, Emily Sims, et al.. (2007). Src family kinase–mediated negative regulation of hematopoietic stem cell mobilization involves both intrinsic and microenvironmental factors. Experimental Hematology. 35(7). 1026–1037. 9 indexed citations
17.
Munugalavadla, Veerendra, Emily Sims, Jianjian Shi, Lei Wei, & Reuben Kapur. (2007). ROCKI Regulates Growth, Maturation and Migration of Mast Cells.. Blood. 110(11). 2191–2191. 1 indexed citations
18.
Munugalavadla, Veerendra, Emily Sims, Jovencio Borneo, Rebecca J. Chan, & Reuben Kapur. (2007). Genetic and pharmacologic evidence implicating the p85α, but not p85β, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis. Blood. 110(5). 1612–1620. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026